Development of breeding populations of rhesus macaques (Macaca mulatta) that are specific pathogen-free for rhesus cytomegalovirus.
Development of breeding colonies of rhesus macaques (Macaca mulatta) that are specific pathogen-free (SPF) for rhesus cytomegalovirus (RhCMV) is relatively straightforward and requires few modifications from current SPF programs. Infants separated from the dam at or within a few days of birth and cohoused with similarly treated animals remain RhCMV seronegative indefinitely, provided they are never directly or indirectly exposed to a RhCMV-infected monkey. By systematically cohousing seronegative animals into larger social cohorts, breeding populations of animals SPF for RhCMV can be established. The additional costs involved in expanding the current definition of SPF status to include RhCMV are incremental compared with the money already being spent on existing SPF efforts. Moreover, the large increase in research opportunities available for RhCMV-free animals arguably would far exceed the development costs. Potential new areas of research and further expansion of existing research efforts involving these newly defined SPF animals would have direct implications for improvements in human health.
Center for Comparative Medicine, University of California-Davis, Davis, CA, USA. pabarry@ucdavis.edu
Peter A
PA
Barry
Lisa
L
Strelow
D000818:Animals; D001947:Breeding / Q000379:methods; D003587:Cytomegalovirus / Q000235:genetics* / Q000302:isolation & purification / Q000472:pathogenicity / Q000502:physiology; D003586:Cytomegalovirus Infections / Q000635:transmission / Q000652:urine / Q000662:veterinary*; D022482:Cytomegalovirus Vaccines / Q000627:therapeutic use; D005260:Female; D005315:Fetal Diseases / Q000517:prevention & control / Q000821:virology; D006799:Housing, Animal; D006801:Humans; D008253:Macaca mulatta / Q000235:genetics / Q000502:physiology* / Q000821:virology; D008297:Male; D051379:Mice; D011247:Pregnancy; D012463:Saliva / Q000821:virology; D013047:Specific Pathogen-Free Organisms / Q000235:genetics* / Q000502:physiology; D014775:Virus Activation
D022482:Cytomegalovirus Vaccines